AQR Capital Management
KIN

AQR Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

AQR Capital Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,254
Closed -$49K – 2189
2020
Q1 		$49K Sell
12,254
-5,593
-31% -$47.5K ﹤0.01% 2008
2019
Q4 		$151K Hold
17,847
– – ﹤0.01% 2042
2019
Q3 		$122K Hold
17,847
– – ﹤0.01% 2067
2019
Q2 		$149K Hold
17,847
– – ﹤0.01% 2010
2019
Q1 		$164K Hold
17,847
– – ﹤0.01% 2100
2018
Q4 		$195K Buy
17,847
+7,587
+74% +$95.6K ﹤0.01% 2083
2018
Q3 		$143K Hold
10,260
– – ﹤0.01% 2237
2018
Q2 		$109K Buy
+10,260
New +$100K ﹤0.01% 2284

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management's KIN Position: Q2 2020 in Review

AQR Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q2 2020, closing a stake of 12,254 shares — an estimated $49K sold.

AQR Capital Management first reported a position in KIN in Q2 2018 and held it in 8 quarters. The position peaked at $195K in Q4 2018. 83 funds tracked by Wall St. Rank hold KIN as of Q2 2020.

  • AQR Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • AQR Capital Management sold 12,254 Kindred Biosciences, Inc. shares in Q2 2020, an estimated $49K.
  • AQR Capital Management first reported a position in Kindred Biosciences, Inc. in Q2 2018 and held it in 8 quarters.
  • AQR Capital Management's Kindred Biosciences, Inc. position peaked at $195K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2020.

Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.